Recent News

• 09.08.2025 - Morgan Stanley Global Healthcare Conference
• 09.08.2025 - Morgan Stanley Global Healthcare Conference
• 09.03.2025 - Citi Biopharma Back to School Conference
• 09.03.2025 - Citi Biopharma Back to School Conference
• 08.27.2025 - ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
• 08.27.2025 - ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
• 08.12.2025 - ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
• 08.12.2025 - ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
• 07.15.2025 - ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
• 07.15.2025 - ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Recent Filings

• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 8-K Current report
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.16.2025 - 8-K12B/A Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)
• 07.15.2025 - EX-99.1 EX-99.1
• 07.15.2025 - 8-K Current report